Japan's Minister of Health, Labor, and Welfare, Keizo Takemi said on the 28th that it was confirmed that it had adverse effects on the kidneys of Kobayashi Pharmaceutical's health-care products containing red yeast. According to Kyodo News and other Japanese media reports, Keizo Takemi said in an interview with reporters on the same day after reporting to Japanese Prime Minister Fumio Kishida that it was confirmed that penicillic acid would adversely affect the kidneys. In addition to mollicylic acid, sample testing confirmed the presence of two other previously unknown compounds. Keizo Takemi said that it is speculated that these substances are all produced by penicillus mixed in the process of cultivating red yeast. According to data from Japan's Ministry of Health, Labor, and Welfare, as of May 27, 5 consumers taking Kobayashi Pharmaceutical's supplements containing red yeast had died, more than 1,600 people had sought medical treatment, and a total of more than 280 people had been hospitalized. (Xinhua News Agency)
日本确认小林制药问题保健品中的软毛青霉酸对肾脏有害
Japan confirms that Kobayashi Pharmaceuticals' problematic supplements are harmful to the kidneys
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.